FOXD2 and thyroid gland carcinoma: Moreover, RIP results indicated that mutation of any four recognition site of miR-7-5p on FOXD2-AS1 differentially reduced the binding of miR-7-5p with FOXD2-AS1 compared with wild-type FOXD2-AS1 in thyroid cancer cells (Figures 6E,F).